Hledání článků
Filtry
Bolée G, Flaman M, Schordan S, et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 2011; doi:10.1038/nm.2491
Dooley MA, Jayne D, Ginzler EM, et al. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 2011;365:1886–1895.
Siddiqi L, Oey PL, Blankestijn PJ. Akiskiren reduces sympathetic nerve aktivity and blood pressure in chronic kidney disease patiens. Nephrol Dial Transpl 2011;26:2930–2934.
Blankestijn PE, Ritz E. Renal denervation:potential impact on hypertension in kidney disease. Nephrol Dial Transpl 2011;26:2732–2734.
Kovesdy CP, Molnár MZ, Czira ME, et al. Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate‑to‑advanced CKD. Nephron Clin Pract 2011;118:c78–c85.
Felker GM, et al., NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011;364:797–805.
Singh V, Dhungana SP, Singh B, Vijayverghia R, Nain CK, Sharma N, Bhalla A, Gupta PK. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study. J Hepatol. 2011, doi:10.1016/j. jhep.2011.04.027
Chrysochou C, Foley RN, Young JF, et al. Dispelling the myth: the use of renin‑angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant. 2011 Oct 12. [Epub ahead of print]
Vaglio A, Palmisano A, Alberici F et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open‑label randomised controlled trial. Lancet 2011;378:338–346.
Fukuda A, et al. Angiotensin II‑dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 2011. doi: 10.1038/ki.2011.306.